2020
DOI: 10.1053/j.semnuclmed.2020.02.005
|View full text |Cite
|
Sign up to set email alerts
|

The Future of Cardiac Molecular Imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 194 publications
0
20
0
1
Order By: Relevance
“…PET-CT is currently the leading molecular test in the diagnosis of unstable carotid plaque, however, focused mainly on the assessment of the inflammation within the plaque. The discovery of new radiotracers (with increased availability, biological sensitivity and more effectively target alternative processes) should change this situation (88). Many of these radiotracers may have been developed and adopted from other domains, such as oncology or neuroimaging.…”
Section: Discussionmentioning
confidence: 99%
“…PET-CT is currently the leading molecular test in the diagnosis of unstable carotid plaque, however, focused mainly on the assessment of the inflammation within the plaque. The discovery of new radiotracers (with increased availability, biological sensitivity and more effectively target alternative processes) should change this situation (88). Many of these radiotracers may have been developed and adopted from other domains, such as oncology or neuroimaging.…”
Section: Discussionmentioning
confidence: 99%
“…Advances in molecular imaging enable the measurement of myocardial energetic deficits and fibrotic activity. 5 A range of plasma and urinary biomarkers that provide an “omic fingerprint” to assess metabolism, inflammation, fibrosis, and hemodynamics may also be used to identify and manage personalized biotargets. Sodium-glucose cotransporter inhibitors may be effective in preventing heart failure in at-risk populations through a variety of putative effects on many of these disease processes.…”
Section: Can We Simplify Treatment Of Remission Based On Phenotype?mentioning
confidence: 99%
“…The combination of PET with CMR in a single acquisition is now possible with the emergence of new hybrid PET-CMR systems, thus the strengths of PET and CMR can be combined. Despite high costs, hybrid scanners can offer great benefits due to the high accuracy and reduced risk of complications [ 66 , 67 ]. The MRI has a high negative predictive value and excellent sensitivity in detecting fibrosis, and the PET is important for its ability to visualize and quantify inflammatory disease activity and extracardiac involvement.…”
Section: 18f-fdg Pet Study Of Cardiac Sarcoidosismentioning
confidence: 99%